LMD-04. FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review. (9th August 2021)

• Record Type: Journal Article
• Authors: Mitsuya, Koichi; Nakasu, Yoko; Deguchi, Shoichi; Shirata, Kensei; Asakura, Koiku; Kazuaki, Nakashima; Takahashi, Toshiaki; Nakamasa, Hayashi
• Is Part Of: Neuro-oncology advances. Volume 3(2021)Supplement 3
• Page Start: iii8
• Page End: iii8
• Publication Date: 2021-08-09
• Subjects: 616.99481
• DOI: 10.1093/noajnl/vdab071.029
• Languages: English
• ISSNs: 2632-2498

Abstract

Abstract: Background: The incidence of leptomeningeal metastasis (LM) is underestimated because of its non-specific signs and the low sensitivity of clinical diagnostic modalities. Cerebrospinal magnetic resonance (MR) imaging with and without contrast enhancement (CE) is a gold standard for the neuroradiological assessment of patients with suspected LM. Previous studies suggested that some LM cases show changes of the brainstem surface on non-contrast MR images without or before the appearance of abnormalities on CE images. We assessed the features of this non-contrast MR finding in a cohort of LM patients in this retrospective single-institution study. Methods: We reviewed head MR images and clinical data of 142 consecutive patients in whom the final diagnosis was LM. Results: We found that 11 of these 142 patients (7.7%) with LM had band-like hyperintensity on the brainstem surface on non-enhanced FLAIR images, which looked like bloomy rind on cheese. Three of seven patients who were examined using diffusion-weighted imaging showed restricted diffusion in the corresponding lesion site. The above-mentioned 11 patients included 10 women and 1 man, with a median age of 61 years. All 11 patients had primary lung adenocarcinoma. Seven patients had symptomatic hydrocephalus. Ten patients had EGFR-mutated and one had ALK-rearrangement adenocarcinomas. Before the diagnosis of LM, 10 patients had undergone systemic therapy with EGFR-TKI or pemetrexed, and 1 patient with ALK inhibitor and bevacizumab. Conclusions: We present a series of patients with bloomy rind sign that is non-enhancing LM reliably detected by FLAIR hyperintensity on the brainstem surface. This finding is rare, but may reflect the spread of cancer cells in both the leptomeningeal membrane and the surface of the brain parenchyma specifically in patients with lung adenocarcinomas. Further study is needed to determine the clinical significance of this sign.